Cargando…

Improved Preservation of Residual Beta Cell Function by Atorvastatin in Patients with Recent Onset Type 1 Diabetes and High CRP Levels (DIATOR Trial)

BACKGROUND: A recent randomized placebo-controlled trial of the effect of atorvastatin treatment on the progression of newly diagnosed type 1 diabetes suggested a slower decline of residual beta cell function with statin treatment. Aim of this secondary analysis was to identify patient subgroups whi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Strom, Alexander, Kolb, Hubert, Martin, Stephan, Herder, Christian, Simon, Marie-Christine, Koenig, Wolfgang, Heise, Tim, Heinemann, Lutz, Roden, Michael, Schloot, Nanette C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3308960/ https://www.ncbi.nlm.nih.gov/pubmed/22448235 http://dx.doi.org/10.1371/journal.pone.0033108

Ejemplares similares

Residual Beta Cell Function in Newly Diagnosed Type 1 Diabetes after Treatment with Atorvastatin: The Randomized DIATOR Trial
por: Martin, Stephan, et al.
Publicado: (2011)

The Systemic Immune Network in Recent Onset Type 1 Diabetes: Central Role of Interleukin-1 Receptor Antagonist (DIATOR Trial)
por: Kolb, Hubert, et al.
Publicado: (2013)

Foodborne Transmission of Bovine Spongiform Encephalopathy to Non-Human Primates Results in Preclinical Rapid-Onset Obesity
por: Strom, Alexander, et al.
Publicado: (2014)

Mechanisms Underlying the Onset of Oral Lipid–Induced Skeletal Muscle Insulin Resistance in Humans
por: Nowotny, Bettina, et al.
Publicado: (2013)

Elevated Levels of the Anti-Inflammatory Interleukin-1 Receptor Antagonist Precede the Onset of Type 2 Diabetes: The Whitehall II Study
por: Herder, Christian, et al.
Publicado: (2009)

ASCOT analysis with atorvastatin shows limits of CRP as indicator of cardiovascular risk
Publicado: (2011)

Digital Diabetes Management: A Literature Review of Smart Insulin Pens
por: Heinemann, Lutz, et al.
Publicado: (2021)

Ketone bodies: from enemy to friend and guardian angel
por: Kolb, Hubert, et al.
Publicado: (2021)

COVID-19-Lockdown hat die akute Inzidenz des Typ-1-Diabetes nicht beeinflusst
por: Schloot, Nanette
Publicado: (2020)

High affinity binding of hydrophobic and autoantigenic regions of proinsulin to the 70 kDa chaperone DnaK
por: Burkart, Volker, et al.
Publicado: (2010)

mCRP as a Biomarker of Adult-Onset Still’s Disease: Quantification of mCRP by ELISA
por: Fujita, Chitose, et al.
Publicado: (2022)

Acute-onset rhabdomyolysis secondary to sitagliptin and atorvastatin interaction
por: Khan, Muhammad Waqas, et al.
Publicado: (2016)

Proinflammatory Cytokines, Adiponectin, and Increased Risk of Primary Cardiovascular Events in Diabetic Patients With or Without Renal Dysfunction: Results from the ESTHER study
por: Schöttker, Ben, et al.
Publicado: (2013)

Inhibition of Rho and Rac Geranylgeranylation by Atorvastatin Is Critical for Preservation of Endothelial Junction Integrity
por: Xiao, Hongbing, et al.
Publicado: (2013)

Adult-Onset Autoimmune Diabetes in Europe Is Prevalent With a Broad Clinical Phenotype: Action LADA 7
por: Hawa, Mohammed I., et al.
Publicado: (2013)

The effect of atorvastatin on pancreatic beta cell requirement in women with polycystic ovary syndrome
por: Sathyapalan, Thozhukat, et al.
Publicado: (2017)

Atorvastatin 10 mg plus ezetimibe versus titration to atorvastatin 40 mg: attainment of European and Canadian guideline lipid targets in high-risk subjects ≥65 years
por: Constance, Christian, et al.
Publicado: (2014)

Monocyte Gene-Expression Profiles Associated With Childhood-Onset Type 1 Diabetes and Disease Risk: A Study of Identical Twins
por: Beyan, Huriya, et al.
Publicado: (2010)

Effect of CRP and Kinetics of CRP in Prognosis of Nasopharyngeal Carcinoma
por: Chen, Ruiwan, et al.
Publicado: (2019)

Transforming Growth Factor-β1 and Incident Type 2 Diabetes: Results from the MONICA/KORA case-cohort study, 1984–2002
por: Herder, Christian, et al.
Publicado: (2009)

Atorvastatin added to interferon beta for relapsing multiple sclerosis: a randomized controlled trial
por: Kamm, Christian Philipp, et al.
Publicado: (2012)

Comparing Beta Cell Preservation Across Clinical Trials in Recent-Onset Type 1 Diabetes
por: Jacobsen, Laura M., et al.
Publicado: (2020)

Predicting the Exception—CRP and Primary Hip Arthroplasty
por: Meier, Marc-Pascal, et al.
Publicado: (2021)

The comparative efficacy of ezetimibe added to atorvastatin 10 mg versus uptitration to atorvastatin 40 mg in subgroups of patients aged 65 to 74 years or greater than or equal to 75 years
por: Ben-Yehuda, Ori, et al.
Publicado: (2011)

The effect of APN, hs-CRP and APN/hs-CRP in periodontitis with DAA
por: Cheng, Rui, et al.
Publicado: (2023)

Sfrp5 increases glucose-stimulated insulin secretion in the rat pancreatic beta cell line INS-1E
por: Carstensen-Kirberg, Maren, et al.
Publicado: (2019)

An Exploratory Study of Itolizumab on the Preservation of Beta Cell Function in Adults with Recent-Onset Type 1 Diabetes
por: Cabrera-Rode, Eduardo, et al.
Publicado: (2022)

A novel diabetes typology: towards precision diabetology from pathogenesis to treatment
por: Herder, Christian, et al.
Publicado: (2022)

CRP - Part 2
por: BASEC,
Publicado: (2023)

Electrochemical evaluation of anti-CRP/CRP interaction for the molecular diagnosis of the cardiovascular risk
por: Rodovalho, Vinícius, et al.
Publicado: (2014)

CRP and IL-1B Gene Polymorphisms and CRP in Blood in Periodontal Disease
por: Auerkari, EI, et al.
Publicado: (2013)

Atorvastatin-induced pancreatitis
por: Prajapati, Samir, et al.
Publicado: (2010)

Atorvastatin (Lipitor) by MCR
por: Zarganes-Tzitzikas, Tryfon, et al.
Publicado: (2019)

Serum Chemerin Concentrations Associate with Beta-Cell Function, but Not with Insulin Resistance in Individuals with Non-Alcoholic Fatty Liver Disease (NAFLD)
por: Hatziagelaki, Erifili, et al.
Publicado: (2015)

SWiss Atorvastatin and Interferon Beta-1b Trial In Multiple Sclerosis (SWABIMS) - rationale, design and methodology
por: Kamm, Christian P, et al.
Publicado: (2009)

Differences in the prevalence of erectile dysfunction between novel subgroups of recent-onset diabetes
por: Maalmi, Haifa, et al.
Publicado: (2021)

CRP/albumin ratio: A promising marker of gram-negative bacteremia in late-onset neonatal sepsis
por: Güneş, Hatice, et al.
Publicado: (2021)

Residual inflammatory risk in coronary heart disease: incidence of elevated high-sensitive CRP in a real-world cohort
por: Peikert, Alexander, et al.
Publicado: (2019)

Residual hearing preservation for cochlear implantation surgery
por: Lin, Chung-Ching, et al.
Publicado: (2021)

Plasma lipid species at type 1 diabetes onset predict residual beta-cell function after 6 months
por: Overgaard, Anne Julie, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_3d2b744i7gqa3b76fol3jia35p